Richard Shellenberger

Dr. Richard Shellenberger

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
MMMacKenzie Mayo
MacKenzie Mayo
BPBindu Potugari
Bindu Potugari
RBRami Bzeih
Rami Bzeih
CSCaleb Scheidel
Caleb Scheidel
CCCarolyn Carrera
Carolyn Carrera
RSRichard Shellenberger
Richard Shellenberger
The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register, ClinicalTrials.gov, and EMBASE without language restrictions for studies published between January 1, 2021, and February 10, 2021. Studies selected for full-text review contained data on patients screened for any type of cancer during the COVID-19 pandemic and comparison data from a time interval just prior to the pandemic. Data were obtained through dual extraction. All the included studies were assessed for quality and risk of bias. A meta-analysis was performed on 13 studies: 7 on screening mammography, 5 on colon cancer screening, and 3 on cervical cancer screening. Two of our studies reported on more than one type of cancer screening. The screening outcomes were reported as pooled incidence rate ratios using the inverse variance method and random effects models. All studies included in our meta-analysis reported the number of patients screened for cancer in defined time intervals before and during the COVID-19 pandemic. We found that the pooled incidence rate ratios were significantly lower for screening during the COVID-19 pandemic for breast cancer (0.63; 95% CI, 0.53 to 0.77; P<.001), colon cancer (0.11; 95% CI, 0.05 to 0.24; P<.001), and cervical cancer (0.10; 95% CI, 0.04 to 0.24; P<.001). These findings may add further morbidity and mortality to this public health crisis.

25 February 2016 in Annals of Medicine
Verified
Journal Article
Closed access
PDF file
RSRichard Shellenberger
Richard Shellenberger
MNMohammed Nabhan
Mohammed Nabhan
SKSweta Kakaraparthi
Sweta Kakaraparthi
Malignant melanoma ranks fifth in the number of new cases annually in the United States (US). Despite increasing incidence and lack of recent improvement in mortality, national melanoma screening guidelines are currently not in existence. Our purpose was to review the evidence regarding screening whole-body skin examinations for early detection and a possible mortality benefit for malignant melanoma. Data sources for our review were MEDLINE Complete, PubMed, Cochrane Library, Cochrane Database of Systematic Reviews, and ClinicalTrials.gov. Study selection included: epidemiologic data from the US and European cancer surveillance registries, population-based case-control screening trials, computer-simulated Markov model trials, and survey trials. Studies were limited to those published in the English language. Data was extracted using a dual extraction method. Data from studies have shown that the mortality of malignant melanoma is highly predicated on the tumor thickness at the time of diagnosis. Our data review is in support of the implementation of whole-body skin examinations, performed by primary care physicians, for the purpose of early detection of melanoma. A large national population-based, case-control, skin cancer screening trial in Germany has shown a reduction in melanoma-specific mortality. In conclusion, our review of the evidence supports physicians performed whole-body skin examination can lead to the detection of earlier stage melanomas as well as to a reduction in disease-specific mortality. We found a paucity of randomized trials to be a limitation of screening studies for many cancers, including melanoma. To improve screening rates and early detection of malignant melanoma, we propose making skin cancer education part of the curriculum in US primary care residency programs to become the genesis for widespread melanoma screening. Our study had no funding. Key messages Malignant melanoma is the fifth leading cancer in the United States (US). In the US and many countries worldwide, the incidence and mortality rates have not declined despite advances seen in the detection and treatment of many cancers. Whole-body skin examination is non-invasive and has shown to be cost effective. There is evidence supporting a mortality benefit using routine, widespread skin cancer examinations. Primary care physicians have been shown to effectively use skin cancer examination for early detection and reduced melanoma mortality. The majority of US primary care residents are inadequately trained in skin cancer examination. There is a possible survival advantage and cost effectiveness for melanoma screening.

14 October 2022 in Cancer Reports
Verified
Journal Article
Open access
RSRichard Shellenberger
Richard Shellenberger
TJTimothy M. Johnson
Timothy M. Johnson
FFFatima Fayyaz
Fatima Fayyaz
BSBhanu Swamy
Bhanu Swamy
JAJeremy Albright
Jeremy Albright
AGAlan C. Geller
Alan C. Geller
Introduction: We sought to identifying the possible existence of disparities between rural and urban residents of Michigan for the incidence by stage of disease and disease‐specific mortality for cutaneous melanoma (CM).Methods: Incidence rates for stage of disease and disease‐specific mortality of cutaneous melanoma were calculated and controlled for gender, age, and area of residence from January 1, 2014, to December 31, 2018, from data collected form the Michigan Department of Health and Human Services and the Centers for Disease Control and Prevention.Results: The incidence rates for CM were significantly higher in rural Michigan counties, from 2014–2018, for all patients, both age groups, both genders and all stages. Melanoma‐specific mortality rates were also significantly higher for all patients, both age groups and both genders in rural Michigan counties. Using logistic regression analysis, while controlling for age and gender, rural Michigan counties continued to have a higher melanoma‐specific morality rate during our study period (OR = 1.491; 95% CI, 1.27–1.74; p = <.001).Conclusion: We found significant disparities in the incidence rates and disease specific mortality for cutaneous melanoma in rural compared to urban Michigan from 2014–2018.

19 December 2024 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
QZQianzi Zhao
Qianzi Zhao
PPPreethika Palani
Preethika Palani
NKNadine S. Kassab
Nadine S. Kassab
MTMilan Terzic
Milan Terzic
MOMonika Olejnik
Monika Olejnik
RSRichard Shellenberger
Richard Shellenberger
Shoulder pain represents a common patient complaint evaluated in a primary care setting. Approximately two thirds of these patients have rotator cuff injuries, with rotator cuff tears (RCTs) and subacromial impingement syndrome (SIS) accounting for a majority of causes. An accurate and efficient diagnostic strategy focused on physical examination findings may lead to improved outcomes and less functional disability. To identify the most accurate physical examination tests for the diagnosis of RCT and SIS, we performed a systematic review and meta-analysis. The database for our systematic review was compiled by using keywords and common indexing strategies to search PubMed, Ovid MEDLINE, Embase and the Cochrane Library from January 1, 1980, to March 15, 2024. Included studies evaluated a physical examination being performed prior to a reference standard diagnostic test for either RCT or SIS. Data was extracted in dual fashion and meta-analyses were performed regarding physical examination tests identified in our included studies. A total of twenty studies, which include 3,438 patients, met our inclusion criteria and had data extracted for statistical analysis. Data was adequate to perform meta-analyses on ten physical examination tests for RCT and five physical examination tests for SIS. There were six physical examination tests which had significant diagnostic odds ratios (DORs) when used in the diagnostic evaluation of suspected RCT, with the External Rotation Lag Sign at 90 Degrees having the highest magnitude of significance (DOR, 12.70; 95% CI, 3.68 – 43.86; P < .0001). Four physical examination tests had significant DORs for physical examination tests when used in the diagnostic evaluation of SIS, with the Yergason’s Test having the highest magnitude of significance (DOR, 4.71; 95% CI; 2.16 – 10.32; P = .0001). We present a large body of low-quality evidence for the diagnostic accuracies of physical examination tests for the identification of both RCT and SIS. We have identified novel data for the accuracy of the External Rotation Lag Sign at 90 Degrees and the Internal Rotation Lag Sign that have high to moderate diagnostic accuracy for ruling in tears of the rotator cuff.

4 March 2025 in Cancer Reports
Verified
Journal Article
Open access
KAKais Antonios
Kais Antonios
DADaniel Aintabi
Daniel Aintabi
PMPatricia McNally
Patricia McNally
EBElliot Berinstein
Elliot Berinstein
PDPriyata Dutta
Priyata Dutta
RSRichard Shellenberger
Richard Shellenberger
Background: Barrett's esophagus (BE) is the most widely established precursor to esophageal adenocarcinoma (EAC). Despite current screening guidelines, more than 90% of EAC patients lack a previous diagnosis of BE. We performed a systematic review and meta‐analysis to identify the most important risk factors for the development of BE or EAC.Recent Findings: PubMed.gov, Ovid Medline, Embase, and Cochrane Library were searched through March 15, 2024. Studies comparing characteristics of patients with endoscopically diagnosed BE or EAC to control groups satisfied our inclusion criteria. Dual extraction provided data for random‐effects meta‐analyses. Sufficient data were extracted from 54 included studies to perform our meta‐analyses. There were five risk factors with significant associations for the development of BE: symptoms of gastroesophageal reflux at least once weekly (OR, 3.56; 95% confidence interval [CI], 2.03–6.25; p = 0.004) tobacco smoking (OR, 1.41; 95% CI, 1.30–1.51; p < 0.001); alcohol use (OR, 1.37; 95% CI, 1.10–1.71; p = 0.008); male gender (OR, 1.36; 95% CI, 1.19–1.57; p < 0.001); and obesity (BMI > 30 kg/m2) (OR, 1.23; 95% CI, 1.09–1.39; p = 0.003). Tobacco smoking was significantly associated with the diagnosis of EAC (OR, 2.15; 95% CI, 1.85–2.43; p < 0.001).Conclusion: Five risk factors showed significant associations with the development of BE and one with the development of EAC, with over a three‐fold increase in BE for patients with gastroesophageal reflux more than once weekly. These data could prove useful in developing diagnostic paradigms with higher emphasis on patients experiencing more frequent acid reflux.

1 January 2017 in Cleveland Clinic Journal of Medicine
Verified
Journal Article
Closed access
RSRichard Shellenberger
Richard Shellenberger
BBBathmapriya Balakrishnan
Bathmapriya Balakrishnan
SASindhu Avula
Sindhu Avula
AEAriadne Ebel
Ariadne Ebel
SSSufiya Shaik
Sufiya Shaik
Release date: December 1, 2017Expiration date: November 30, 2018Estimated time of completion: 1 hourClick here to start this CME activity.Click here to complete post-test and CME certificate.ABSTRACTWe reviewed the evidence for the diagnostic accuracy of the physical examination in diagnosing pneumonia, pleural effusion, chronic obstructive pulmonary disease, and congestive heart failure in patients with dyspnea and found that the physical examination has reliable diagnostic accuracy for these common conditions.